Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Genfit S.A. sell BiotechBee

Genfit S.A.
Start price
€3.56
27.06.23 / 70%
Target price
€1.50
31.01.26
Performance (%)
-19.10%
End price
€2.88
20.10.23
Summary
This prediction ended on 20.10.23 with a price of €2.88. The price of Genfit S.A. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -19.10%. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Genfit S.A. 9.987% 9.987% 43.137%
iShares Core DAX® 0.734% -0.964% 17.910%
iShares Nasdaq 100 -2.686% -2.409% 4.267%
iShares Nikkei 225® -2.261% -4.038% 10.420%
iShares S&P 500 -1.346% -1.510% 1.615%

According to BiotechBee what are the pros and cons of Genfit S.A. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Genfit S.A. diskutieren
Prediction Sell
Perf. (%) -19.10%
Target price 1.500
Change
Ends at 31.01.26

Sell mit Kursziel 1,5

BiotechBee 
0
Report Share
27.06.23
In the thread Trading Genfit S.A.
Prediction Sell
Perf. (%) -19.10%
Target price 1.500
Change
Ends at 31.01.26

Sell beendet

BiotechBee 
0
Report Share
20.10.23

Stopped prediction by BiotechBee for Genfit S.A.

buy
Genfit S.A.

Start price
Target price
Perf. (%)
€3.32
10.12.23
€4.90
31.05.25
5.43%
17.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
10.12.23 50%